The effect of combination of Fenofibrate and Pioglitazone to atherosclerosis of metabolic syndrome

Chen-fang WU,Wen PENG,Xiang-ping CHAI,Sheng-hua ZHOU,Yu-mei LUO

DOI: https://doi.org/10.3969/j.issn.1673-6966.2014.02.011

2014-01-01

Abstract:Objective To explore the effect of Fenofibrate and pioglitazone combination intervention for atherosclerosis of metabolic syndrome (MS) patients. Methods 242 MS patients were randomly divided into basic treatment group (n=64), fenofibrate group (n=65), pioglitazone group (n=63), and Fenofibrate and Pioglitazone combination group (n=64). All patients went through lifestyle intervention and appropriate medication to control blood pressure. Fenofibrate group took fenofibrate 0.2g once a day while Pioglitazone group took pioglitazone 15mg once a day;the combination group took both of the above drugs as described. The intervention lasted for 24 weeks. The carotid intima-media thickness and the positive rate of atheromatous plaque were detected by type-B ultrasonic, and the serum concentration of MMP-9 was detected by ELISA before and after intervene. Results Comparing with Fenofibrate group, both of the carotid intima-media thickness and the positive rate of atheromatous plaque of combination group declined; comparing with Pioglitazone group, carotid intima-media thickness of combination group declined, but it reflected on significant difference on the positive rate of atheromatous plaque;the serum concentration of MMP-9 in combination group declined more than Fenofibrate group and Pioglitazone group, respectively. Conclusion Combination of Fenofibrate and Pioglitazone intervene is considered being more effective than either Fenofibrate or Pioglitazone application.